Published in Eur Urol on June 04, 2010
Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer. Eur Urol (2015) 3.46
Surgical resection of urological tumor metastases following medical treatment. Dtsch Arztebl Int (2012) 1.34
Survival impact of followup care after radical cystectomy for bladder cancer. J Urol (2013) 0.80
Multifactorial, site-specific recurrence models after radical cystectomy for urothelial carcinoma: external validation in a cohort of Korean patients. PLoS One (2014) 0.78
Prognostic value of vascular mimicry in patients with urothelial carcinoma of the bladder after radical cystectomy. Oncotarget (2016) 0.75
Pulmonary and chest wall metastasectomy in urogenital tumors: a single center experience and review of literature. Nephrourol Mon (2014) 0.75
Contrast enhanced computed tomography characterization of fluorodeoxygluocose-avid regional and non-regional lymph nodes in patients with suspicion of metastatic bladder cancer. J Clin Imaging Sci (2013) 0.75
Sources of variation in follow-up expenditure after radical cystectomy. Urol Oncol (2015) 0.75
Invasive bladder cancer and the role of follow-up: should we consider the match over at radical cystectomy or should we play for extra time? Eur Urol (2010) 0.75
Surgical treatment of recurrent urachal carcinoma with liver metastasis: a case report and literature review. World J Surg Oncol (2016) 0.75
A Rare Metastatic Myositis Ossificans of Obturator Muscle Secondary to Urothelial Carcinoma. Rare Tumors (2015) 0.75
SKIP expression is correlated with clinical prognosis in patients with bladder cancer. Int J Clin Exp Pathol (2014) 0.75
Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer. Oncotarget (2017) 0.75
Oncologic surveillance following radical cystectomy: an individualized risk-based approach. World J Urol (2017) 0.75
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (2009) 7.44
Pelvic lymph node dissection in prostate cancer. Eur Urol (2009) 3.93
Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol (2003) 3.58
Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit? Eur Urol (2011) 3.47
Long-term renal function after urinary diversion by ileal conduit or orthotopic ileal bladder substitution. Eur Urol (2011) 3.44
The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Eur Urol (2007) 3.20
Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol (2008) 2.83
Twenty years experience with an ileal orthotopic low pressure bladder substitute--lessons to be learned. J Urol (2006) 2.82
Contemporary role of androgen deprivation therapy for prostate cancer. Eur Urol (2011) 2.68
Urinary diversion. Urology (2007) 2.65
Nerve sparing open radical retropubic prostatectomy--does it have an impact on urinary continence? J Urol (2006) 2.65
A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol (2009) 2.55
Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Eur Urol (2008) 2.46
Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy. J Clin Oncol (2003) 2.33
Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer? Eur Urol (2006) 2.32
Restrictive deferred hydration combined with preemptive norepinephrine infusion during radical cystectomy reduces postoperative complications and hospitalization time: a randomized clinical trial. Anesthesiology (2014) 2.25
Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer. Eur J Cancer (2012) 2.15
Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol (2011) 2.14
Complete continence after botulinum neurotoxin type A injections for refractory idiopathic detrusor overactivity incontinence: patient-reported outcome at 4 weeks. Eur Urol (2009) 2.04
Occlusion of seminal vesicles increases sexual activity in a mouse model. Eur Urol (2012) 2.03
Influence of epidural mixture and surgery on bladder function after open renal surgery: a randomized clinical trial. Anesthesiology (2013) 1.98
Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses. Eur Urol (2012) 1.96
A prospective randomized trial comparing 2 lithotriptors for stone disintegration and induced renal trauma. J Urol (2003) 1.84
Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging. Radiology (2014) 1.78
Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment. Eur Urol (2008) 1.73
Radionecrosis or tumor recurrence after radiation of laryngeal and hypopharyngeal carcinomas. Otolaryngol Head Neck Surg (2006) 1.69
Long-term results of standard procedures in urology: the ileal neobladder. World J Urol (2006) 1.68
Extracorporeal shock wave lithotripsy of lower calyx calculi: how much is treatment outcome influenced by the anatomy of the collecting system? Eur Urol (2007) 1.68
Is newer always better? A comparative study of 3 lithotriptor generations. J Urol (2005) 1.67
Ultrasound assessment of detrusor thickness in men-can it predict bladder outlet obstruction and replace pressure flow study? J Urol (2006) 1.65
Individualized seminal vesicle sparing cystoprostatectomy combined with ileal orthotopic bladder substitution achieves good functional results. J Urol (2010) 1.64
A prospective randomised trial comparing the modified HM3 with the MODULITH® SLX-F2 lithotripter. Eur Urol (2011) 1.61
Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder. Am J Surg Pathol (2005) 1.61
Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. Eur Urol (2008) 1.60
Is there an indication for frozen section examination of the ureteral margins during cystectomy for transitional cell carcinoma of the bladder? J Urol (2006) 1.59
Renal oxygenation changes during acute unilateral ureteral obstruction: assessment with blood oxygen level-dependent mr imaging--initial experience. Radiology (2008) 1.58
Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy? J Urol (2004) 1.56
Increased proximal urethral sensory threshold after radical pelvic surgery in women. Neurourol Urodyn (2007) 1.53
Parenteral nutrition does not improve postoperative recovery from radical cystectomy: results of a prospective randomised trial. Eur Urol (2012) 1.52
Long-term voiding pattern of patients with ileal orthotopic bladder substitutes. J Urol (2002) 1.50
Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol (2002) 1.50
Long-term outcome of ileal conduit diversion. J Urol (2003) 1.50
The efficiency of excretory urography to detect upper urinary tract tumors after cystectomy for urothelial cancer. J Urol (2007) 1.49
The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol (2009) 1.49
Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided? J Urol (2009) 1.45
Is bilateral extended pelvic lymphadenectomy necessary for strictly unilateral invasive bladder cancer? J Urol (2012) 1.45
Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy. BJU Int (2014) 1.44
ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary diversion. Eur Urol (2012) 1.42
Is eligibility for a chemotherapy protocol a good prognostic factor for invasive bladder cancer after radical cystectomy? J Clin Oncol (2004) 1.40
Refractory chronic pelvic pain syndrome in men: can transcutaneous electrical nerve stimulation help? BJU Int (2013) 1.40
Effect of thalamic deep brain stimulation on lower urinary tract function. Eur Urol (2007) 1.40
Diabetes mellitus: does it impair urinary continence after radical cystoprostatectomy and ileal orthotopic bladder substitution? Eur Urol (2007) 1.39
Robot-assisted cystectomy: does it meet expectations? Eur Urol (2010) 1.37
Irrigation of continent catheterizable ileal pouches: tap water can replace sterile solutions because it is safe, easy, and economical. Eur Urol (2011) 1.37
Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours. Eur Urol (2011) 1.24
Holmium laser enucleation of the prostate combined with electrocautery resection: the mushroom technique. J Urol (2002) 1.16
Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol (2005) 1.14
Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study. Anesthesiology (2010) 1.10
Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks. Eur Urol (2008) 1.08
MicroRNAs may mediate the down-regulation of neurokinin-1 receptor in chronic bladder pain syndrome. Am J Pathol (2009) 1.07
Evaluation of renal allograft function early after transplantation with diffusion-weighted MR imaging. Eur Radiol (2009) 1.07
Diffusion-weighted MR imaging of upper abdominal organs: field strength and intervendor variability of apparent diffusion coefficients. Radiology (2013) 1.07
Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity? Neurourol Urodyn (2005) 1.07
Alternate or additional findings to stone disease on unenhanced computerized tomography for acute flank pain can impact management. J Urol (2006) 1.06
Survival in surgically treated, nodal positive prostate cancer patients is predicted by histopathological characteristics of the primary tumor and its lymph node metastases. Prostate (2009) 1.05
Nerve-sparing open radical retropubic prostatectomy. Eur Urol (2006) 1.04
Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol (2009) 1.03
Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades. BJU Int (2013) 1.03
What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type a injection. J Urol (2009) 0.99
Is ileal orthotopic bladder substitution with an afferent tubular segment detrimental to the upper urinary tract in the long term? J Urol (2002) 0.99
Leg ischemia: assessment with MR angiography and spectroscopy. Radiology (2005) 0.97
Can radical prostatectomy benefit patients despite the presence of regional metastases? Eur Urol (2010) 0.97
Lymph node dissection in renal cell carcinoma. Eur Urol (2011) 0.97
Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J Urol (2002) 0.96
Indications, extent, and benefits of pelvic lymph node dissection for patients with bladder and prostate cancer. Oncologist (2009) 0.96
Matrix metalloproteinases and angiogenic factors: predictors of survival after radical prostatectomy for clinically organ-confined prostate cancer? Am J Pathol (2010) 0.95
Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection. Eur Urol (2002) 0.95
Long-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-A for detrusor overactivity in patients with multiple sclerosis. J Urol (2011) 0.94
Extracorporeal shock wave lithotripsy for distal ureteral calculi: what a powerful machine can achieve. J Urol (2003) 0.94
Air charged and microtip catheters cannot be used interchangeably for urethral pressure measurement: a prospective, single-blind, randomized trial. J Urol (2008) 0.93
A critical analysis of orthotopic bladder substitutes in adult patients with bladder cancer: is there a perfect solution? Eur Urol (2010) 0.93
Ureteroileal strictures after urinary diversion with an ileal segment-is there a place for endourological treatment at all? J Urol (2013) 0.93
Cancer of the oral cavity and oropharynx. Cancer Imaging (2010) 0.93